Select Medical Declares Quarterly Dividend Amid Solid Results

An update from Select Medical ( (SEM) ) is now available.

Select Medical reported stronger financial performance for the fourth quarter and full year ended December 31, 2025, with quarterly revenue up 6.4% to $1.40 billion and full-year revenue up 5.1% to $5.45 billion. Income from continuing operations surged in both periods, aided by the absence of 2024 one-time charges tied to the November 25, 2024 tax-free spin-off of Concentra, though Adjusted EBITDA declined modestly year over year.

Segment results were mixed, with rehabilitation hospitals delivering double-digit revenue and EBITDA growth, critical illness recovery hospitals showing modest revenue gains but margin compression, and outpatient rehabilitation posting slight revenue growth. On November 24, 2025, Executive Chairman and co-founder Robert A. Ortenzio made a non-binding proposal to take the company private at $16.00–$16.20 per share, prompting the board’s independent special committee to review the offer and evaluate broader strategic alternatives, while the board also declared a quarterly cash dividend of $0.0625 per share on February 12, 2026 for payment in March 2026.

The most recent analyst rating on (SEM) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.

Spark’s Take on SEM Stock

According to Spark, TipRanks’ AI Analyst, SEM is a Neutral.

Select Medical’s overall stock score reflects a combination of strong earnings call performance and positive technical indicators, offset by financial risks related to high leverage and declining cash flow growth. The valuation is moderate, providing some stability.

To see Spark’s full report on SEM stock, click here.

More about Select Medical

Select Medical Holdings is one of the largest U.S. operators of critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics. As of December 31, 2025, it ran 104 critical illness recovery hospitals in 28 states, 38 rehabilitation hospitals in 15 states and 1,917 outpatient rehab clinics across 39 states and Washington, D.C.

The company reports through three segments: critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation, focusing on post-acute and specialty care services. Its nationwide footprint positions Select Medical as a major player in U.S. post-acute healthcare services and facility-based rehabilitation markets.

Average Trading Volume: 934,355

Technical Sentiment Signal: Strong Buy

Current Market Cap: $2.03B

Learn more about SEM stock on TipRanks’ Stock Analysis page.